Roche Holding AG (RHHBY)
53.70
-1.49
(-2.70%)
USD |
OTCM |
Aug 31, 16:00
Roche Cash from Operations (TTM) : 23.75B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.75B |
| December 31, 2025 | 22.29B |
| June 30, 2025 | 21.23B |
| December 31, 2024 | 22.00B |
| June 30, 2024 | 17.61B |
| December 31, 2023 | 17.50B |
| June 30, 2023 | 17.38B |
| December 31, 2022 | 18.53B |
| June 30, 2022 | 23.05B |
| December 31, 2021 | 22.36B |
| June 30, 2021 | 21.64B |
| December 31, 2020 | 19.91B |
| June 30, 2020 | 21.36B |
| December 31, 2019 | 22.10B |
| June 30, 2019 | 19.41B |
| December 31, 2018 | 19.61B |
| June 30, 2018 | 18.38B |
| December 31, 2017 | 17.86B |
| June 30, 2017 | 16.62B |
| December 31, 2016 | 14.34B |
| June 30, 2016 | 13.58B |
| December 31, 2015 | 14.63B |
| June 30, 2015 | 14.40B |
| December 31, 2014 | 15.96B |
| June 30, 2014 | 17.19B |
| Date | Value |
|---|---|
| December 31, 2013 | 15.83B |
| June 30, 2013 | 14.53B |
| December 31, 2012 | 14.29B |
| June 30, 2012 | 13.52B |
| December 31, 2011 | 13.18B |
| June 30, 2011 | 13.96B |
| December 31, 2010 | 12.44B |
| June 30, 2010 | 13.27B |
| December 31, 2009 | 15.77B |
| June 30, 2009 | 13.24B |
| December 31, 2008 | 11.28B |
| June 30, 2008 | 13.65B |
| December 31, 2007 | 10.67B |
| June 30, 2007 | 7.352B |
| December 31, 2006 | 8.758B |
| June 30, 2006 | 7.951B |
| December 31, 2005 | 7.893B |
| June 30, 2005 | 6.074B |
| December 31, 2004 | 5.819B |
| June 30, 2004 | 6.134B |
| December 31, 2003 | 5.262B |
| June 30, 2003 | 1.831B |
| December 31, 2002 | 537.59M |
| June 30, 2002 | 2.348B |
| December 31, 2001 | 2.995B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Novartis AG | 18.41B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |
| AstraZeneca PLC | 14.54B |
| Pfizer Inc. | 13.40B |